Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma.

Primary open angle (POAG) and pseudoexfoliative glaucoma (PXG) are the most common primary and secondary forms of glaucoma, respectively. Even though the patho-physiology, aqueous humor composition, risk factors, clinical features, therapy and drug induced ocular surface changes in POAG and PXG have been widely studied, to date information concerning tear protein characterization is lacking. Tears are a source of nourishment for ocular surface tissues and a vehicle to remove local waste products, metabolized drugs and inflammatory mediators produced in several ophthalmic diseases. In glaucoma, the proteomic definition of tears may provide insights concerning patho-physiology of the disease and ocular surface modifications induced by topical therapy. Our study aimed at characterizing protein patterns in tears of patients with medically controlled POAG and PXG. A comparative tears proteomic analysis by label-free LC-MS(E) highlighted differences in the expression of several proteins in the two glaucoma sub-types and control subjects, highlighting inflammation pathways expressed in both diseases. Results were independently reconfirmed by SDS-PAGE and linear MALDI-TOF MS, validating altered levels of Lysozyme C, Lipocalin-1, Protein S100, Immunoglobulins and Prolactin Inducible Protein. Moreover, we found a differential pattern of phosphorylated Cystatin-S that distinguishes the two pathologies. The most relevant results suggest that in both pathologies there may be active inflammation pathways related to the disease and/or induced by therapy. We show, for the first time, tear protein patterns expressed under controlled intraocular pressure conditions in POAG and PXG subjects. These findings could help in the understanding of molecular machinery underlying these ophthalmologic diseases, resulting in early diagnosis and more specific therapy.

[1]  R. Beuerman,et al.  Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. , 2011, Investigative ophthalmology & visual science.

[2]  L. Pieroni,et al.  New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation. , 2011, Journal of proteome research.

[3]  T. Sobrino,et al.  Proteomic analysis of the tear film in patients with keratoconus , 2010, Molecular vision.

[4]  N. Angayarkanni,et al.  Two dimensional electrophoretic analysis of human tears: Collection method in dry eye syndrome , 2010, Electrophoresis.

[5]  C. Baudouin,et al.  Preservatives in eyedrops: The good, the bad and the ugly , 2010, Progress in Retinal and Eye Research.

[6]  Yong Li,et al.  Post‐translation modification of proteins in tears , 2010, Electrophoresis.

[7]  D. Porteous,et al.  Sputum and serum calprotectin are useful biomarkers during CF exacerbation. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[8]  Dante Mantini,et al.  Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. , 2010, Journal of proteomics.

[9]  R. Shiu,et al.  Generation and initial characterization of the prolactin-inducible protein (PIP) null mouse: accompanying global changes in gene expression in the submandibular gland. , 2009, Canadian journal of physiology and pharmacology.

[10]  Manuela Truebano,et al.  The consequences of sample pooling in proteomics: An empirical study , 2009, Electrophoresis.

[11]  M. Herzberg,et al.  Calprotectin S100A9 Calcium-binding Loops I and II Are Essential for Keratinocyte Resistance to Bacterial Invasion* , 2009, Journal of Biological Chemistry.

[12]  A. Alm,et al.  Pseudoexfoliation as a risk factor for prevalent open‐angle glaucoma , 2008, Acta ophthalmologica.

[13]  N. Gupta,et al.  Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging , 2008, British Journal of Ophthalmology.

[14]  Kari B. Green-Church,et al.  Investigation of the human tear film proteome using multiple proteomic approaches , 2008, Molecular vision.

[15]  A. Clark,et al.  Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues. , 2008, Investigative ophthalmology & visual science.

[16]  B. Glasgow,et al.  Tear lipocalin is the major endonuclease in tears , 2008, Molecular vision.

[17]  N. Pfeiffer,et al.  Autoimmunity and Glaucoma , 2008, Journal of glaucoma.

[18]  D. Gambi,et al.  Cleavage of cystatin C is not associated with multiple sclerosis , 2007, Annals of neurology.

[19]  Johannes P. C. Vissers,et al.  Analysis and Quantification of Diagnostic Serum Markers and Protein Signatures for Gaucher Disease*S , 2007, Molecular & Cellular Proteomics.

[20]  Dante Mantini,et al.  LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise , 2007, BMC Bioinformatics.

[21]  N. Saitou,et al.  Origin and evolution of gene for prolactin-induced protein. , 2006, Gene.

[22]  G. Bernardi,et al.  Differential post‐translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid , 2006, Proteomics.

[23]  A. Izzotti,et al.  The role of oxidative stress in glaucoma. , 2006, Mutation research.

[24]  D. Foell,et al.  Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. , 2005, Blood.

[25]  I. Korndörfer,et al.  The 1.8-Å Crystal Structure of Human Tear Lipocalin Reveals an Extended Branched Cavity with Capacity for Multiple Ligands* , 2005, Journal of Biological Chemistry.

[26]  A. Ringvold Electron microscopy of the limbal conjunctiva in eyes with pseudo-exfoliation syndrome (PE syndrome) , 2004, Virchows Archiv A.

[27]  Anders Heijl,et al.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. , 2003, Archives of ophthalmology.

[28]  B. Redl,et al.  Antisense Down-regulation of Lipocalin-interacting Membrane Receptor Expression Inhibits Cellular Internalization of Lipocalin-1 in Human NT2 Cells* , 2003, The Journal of Biological Chemistry.

[29]  K. Okuda,et al.  Salivary cystatins induce interleukin-6 expression via cell surface molecules in human gingival fibroblasts. , 2002, Molecular immunology.

[30]  Ronald S. Harwerth,et al.  Visual field defects and neural losses from experimental glaucoma , 2002, Progress in Retinal and Eye Research.

[31]  A. Görg,et al.  Improved silver staining protocols for high sensitivity protein identification using matrix‐assisted laser desorption/ionization‐time of flight analysis , 2001, Proteomics.

[32]  B. Redl,et al.  The N-Terminal Part of Recombinant Human Tear Lipocalin/von Ebners Gland Protein Confers Cysteine Proteinase Inhibition Depending on the Presence of the Entire Cystatin-Like Sequence Motifs , 2001, Biological chemistry.

[33]  P. Pelosi,et al.  Expression of a Lipocalin in Human Nasal Mucosa , 1997 .

[34]  E. Veerman,et al.  The Salivary Lipocalin Von Ebner's Gland Protein Is a Cysteine Proteinase Inhibitor* , 1997, The Journal of Biological Chemistry.

[35]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[36]  A. Gachon,et al.  Cloning of a human lacrimal lipocalin secreted in tears. , 1993, Experimental eye research.

[37]  D. Booth,et al.  Human lysozyme gene mutations cause hereditary systemic amyloidosis , 1993, Nature.

[38]  R. Eagle,et al.  Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. , 1992, Archives of ophthalmology.

[39]  E. Saitoh,et al.  Identification of full-sized forms of salivary (S-type) cystatins (cystatin SN, cystatin SA, cystatin S, and two phosphorylated forms of cystatin S) in human whole saliva and determination of phosphorylation sites of cystatin S. , 1991, Journal of biochemistry.

[40]  F. Oppenheim,et al.  Salivary cystatin SA-III, a potential precursor of the acquired enamel pellicle, is phosphorylated at both its amino- and carboxyl-terminal regions. , 1991, Archives of biochemistry and biophysics.

[41]  B. Streeten,et al.  Pseudoexfoliative fibrillopathy in the skin of patients with ocular pseudoexfoliation. , 1990, American journal of ophthalmology.

[42]  A. Ringvold ON THE OCCURRENCE OF PSEUDO‐EXFOLIATION MATERIAL IN EXTRABULBAR TISSUE FROM PATIENTS WITH PSEUDO‐EXFOLIATION SYNDROME OF THE EYE , 1973, Acta ophthalmologica.